Conference Coverage
Conference Coverage
Mammography after breast cancer: No benefit for older patients?
“Ongoing surveillance mammography in these patients may lead to overdiagnosis and overtreatment of cancers that potentially would not harm...
Conference Coverage
Intraoperative pathology spurs overtreatment in mastectomy
“This study suggests that surgeons should delay ALND decision-making until a later time to avoid overtreating patients.”
Conference Coverage
Phase 3 trial: Maribavir yields post-transplant benefits
Study findings “provide supportive evidence of the potential for long-term benefit” with maribavir for the treatment of post-transplant CMV.
Conference Coverage
Expert discusses which diets are best, based on the evidence
The Mediterranean diet is not only helpful for losing weight but also can reduce the risk of various chronic diseases.
Latest News
Controlled hyperthermia: Novel treatment of BCCs without surgery continues to be refined
A novel, noninvasive technique of controlled hyperthermia and mapping protocol designed to help clinicians with margin assessment and treatment of...
Conference Coverage
Experts debate reducing ASCT for multiple myeloma
Overall survival following multidrug regimens and transplant are on par, raising questions about the best frontline therapy for multiple myeloma...
Conference Coverage
Prostate biopsies a laughing (gas) matter?
“At levels of less than 50%, patients respond normally to verbal commands and maintain normal airway reflexes.”
Conference Coverage
Drug combo improves recurrence-free survival after HCC resection
Study shows significant improvement in recurrence-free survival with atezolizumab and bevacizumab combo.
Conference Coverage
Liver transplants for CRC metastases: Coming into its own?
Transplantation is emerging as an attractive option for select patients with nonresectable CRC liver metastases, and patients with intrahepatic...
Conference Coverage
Guidelines for assessing cancer risk may need updating
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
Conference Coverage
Frontline CLL treatment: Avoiding adverse events
Single-agent frontline therapy helps patients with CLL live longer, but those at high risk of relapse may benefit from multiagent treatment.